Matter Bio Successfully Closes $7M Seed Funding Round

Matter Bio tackles the problem of genome instability holistically, addressing the issue through a multi-pronged approach: Matter Bio tackles the problem of genome instability holistically, addressing the issue through a multi-pronged approach: Matter Bio has assembled a world-class team of scientists and executives, including co-founders such asGeorge Church, PhD, a pioneer in genome sequencing and gene editing, Jan Vijg, PhD, an expert in genome instability and somatic mutations, and...

Matter Bio tackles the problem of genome instability holistically, addressing the issue through a multi-pronged approach:

Matter Bio has assembled a world-class team of scientists and executives, including co-founders such as George Church, PhD, a pioneer in genome sequencing and gene editing, Jan Vijg, PhD, an expert in genome instability and somatic mutations, and Claudia Gravekamp, PhD, a world authority in attenuated bacterial therapeutics. The company operates at the forefront of longevity biotechnology, leveraging cutting-edge science and innovative approaches to address the complexities of aging.

"Genomic integrity is a cornerstone of longevity and healthspan extension," said George Church, Professor of Genetics at Harvard Medical School. "Matter Bio is pioneering a crucial approach in the fight against aging by focusing on the preservation of our genetic blueprint. I am excited to see the impact of their work on enhancing human health."

"Our investment in Matter Bio furthers our mission of supporting the cutting-edge interventions that promote longevity and combat aging," said Andrew Worden, Founding Partner of LifeSpan Vision Ventures. "Matter Bio's strong team, cutting-edge genomic preservation technologies, and early-stage partnerships give the company excellent prospects to succeed with its vision."

For more information about Matter Bio's history and mission, please visit matterbio.com.

Media Contact:
[email protected]

 

View original content:https://www.prnewswire.co.uk/news-releases/matter-bio-successfully-closes-7m-seed-funding-round-302157811.html